GlaxoSmithKline Research and Development Limited
Records under this name other than the patents GlaxoSmithKline Research and Development Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Back to GlaxoSmithKline Research and Development Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,216,967 | Imidazolidinedione Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 9,849,131 | Imidazolidinedione Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 10,632,118 | Imidazolidinedione Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,722,695 | Imidazolidinedione Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 8,541,451 | Crystalline Freebase Forms of a Biphenyl Compound Formerly held In force · High confidence | In force | High confidence | |
| US 10,265,316 | Hydantoin Derivatives Useful as KV3 Inhibitors Formerly held In force · Low confidence | In force | Low confidence | |
| US 11,197,859 | Hydantoin Derivatives Useful as KV3 Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,583,527 | Hydantoin Derivatives Useful as KV3 Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,193,704 | Hydantoin Derivatives as KV3 Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 9,346,790 | Hydantoin Derivatives Useful as KV3 Inhibitors Formerly held In force · High confidence | In force | High confidence |